NanoVibronix Inc. (NAOV)
3.84
-0.07 (-1.79%)
At close: Mar 28, 2025, 3:54 PM
3.67
-4.39%
After-hours: Mar 28, 2025, 06:54 PM EDT
-1.79% (1D)
| Bid | 3.51 |
| Market Cap | 3.04M |
| Revenue (ttm) | 930.29K |
| Net Income (ttm) | -872.62K |
| EPS (ttm) | -13.53 |
| PE Ratio (ttm) | -0.28 |
| Forward PE | -0.48 |
| Analyst | n/a |
| Ask | 3.84 |
| Volume | 29,698 |
| Avg. Volume (20D) | 1,077,930 |
| Open | 3.84 |
| Previous Close | 3.91 |
| Day's Range | 3.74 - 3.84 |
| 52-Week Range | 1.92 - 13.97 |
| Beta | 1.81 |
About NAOV
NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter...
Industry Medical - Devices
Sector Healthcare
IPO Date May 28, 2015
Employees 10
Stock Exchange NASDAQ
Ticker Symbol NAOV
Website https://www.nanovibronix.com
1 week ago
+55.2%
NanoVibronix shares are trading higher on possible...
Unlock content with
Pro Subscription
2 weeks ago
-32.16%
NanoVibronix shares are trading lower after the company announced a 1-for-11 reverse stock split.
1 month ago · businesswire.com
NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp.ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (the “Company”), a medical technology company specializing in non-invasive therapeutic devices, today announced the completion of the...
